Brain Neoplasms, Leukemia and Petrochemical Exposures

Sponsor
National Institute of Environmental Health Sciences (NIEHS) (NIH)
Overall Status
Completed
CT.gov ID
NCT00042445
Collaborator
Harvard School of Public Health (HSPH) (Other), Kaohsiung Medical University (Other)
1,456
2
59
728
12.3

Study Details

Study Description

Brief Summary

The aim of this study is to examine the association of exposure to air contaminants (PAH & VOC) emitted from the petrochemical industries, specific genetic polymorphisms (P4501A1 (MspI & exon 7) and GSTM1 & T1) of study subjects and their parents, and the risks of brain tumors and leukemia among children and youths in metropolitan Kaohsiung, southern Taiwan.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Brain tumors and leukemia are the most common malignancies among children and adolescents in the U.S. Adequate information on the role of inherited genetic susceptibility and environmental exposures in the development of neoplasms in children and adolescents is lacking. In Taiwan, four large petrochemical industries are located in the Kaohsiung metropolitan area. These facilities are proximal to residential areas because of the high population density in the region. Data have shown that the concentrations of ambient polycyclic aromatic hydrocarbons (PAH) and volatile organic compounds (VOC) around the petrochemical industries are at least 10 and 2 times, respectively, higher than those in U.S. industrialized communities. Our preliminary case-control study in metropolitan Kaohsiung showed that young residents (under age 30) living within 3 kilometers of the vicinity of petrochemical industries have a 6.0 fold increase in brain neoplasms and a 2.9 fold increase in leukemia. The purpose of this proposal is to examine the association of exposure to air contaminants (PAH and VOC) emitted from the petrochemical industries, specific genetic polymorphisms (P4501A1 (MspI & exon 7) and GSTM1 &T1) from study subjects and their parents, and the risks of brain tumors and leukemia among children and youths in metropolitan Kaohsiung. Our hypothesis is that there is an increased risk of brain tumors and leukemia in patients with high cumulative exposure to these hazards, and that heritable polymorphisms in several genes modify this association. In addition to an independent association of environmental and genetic factors with brain neoplasms and leukemia, we hypothesize that there is greater risk associated with the presence of combined environmental exposure and the high risk genotype. Also, we will assess the role of parental genetic polymorphisms in the development of cancer in their siblings. This proposed study uses an environmental molecular epidemiologic approach, utilizing prospective enrollment of a cohort of brain tumor and leukemia subjects in a population-based case-control design. This proposal is responsive to the recommendation of the National Research Council that risk assessment and public health policy pay special attention to the protection of children.

    Study Design

    Study Type:
    Observational
    Observational Model:
    Case-Control
    Study Start Date :
    Aug 1, 2000
    Study Completion Date :
    Jul 1, 2005

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      0 Years to 30 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No

      Young population Less than 30 Resident of Kaohsiung metropolitan, Taiwan

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Harvard School of Public Health Boston Massachusetts United States 02115
      2 Kaohsiung Medical University Kaohsiung Taiwan 80708

      Sponsors and Collaborators

      • National Institute of Environmental Health Sciences (NIEHS)
      • Harvard School of Public Health (HSPH)
      • Kaohsiung Medical University

      Investigators

      None specified.

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT00042445
      Other Study ID Numbers:
      • 9723-CP-001
      First Posted:
      Aug 1, 2002
      Last Update Posted:
      Sep 4, 2006
      Last Verified:
      Sep 1, 2006
      Keywords provided by , ,
      Additional relevant MeSH terms:

      Study Results

      No Results Posted as of Sep 4, 2006